European Journal of Cancer Q1 Unclaimed
European Journal of Cancer is a journal indexed in SJR in Oncology and Cancer Research with an H index of 205. Journal with a Single blind Peer Review review system, and It has a price of 2655 €. The scope of the journal is focused on Cancer, Oncology, Clinical Oncology, Medicine. It has an SJR impact factor of 3,41 and it has a best quartile of Q1. It is published in English.
Type: Journal
Type of Copyright:
Languages: English
Open Access Policy: Open Choice
Type of publications:
Publication frecuency: -
2655 €
Gold OA-
Green OA- €
Non OAMetrics
3,41
SJR Impact factor205
H Index352
Total Docs (Last Year)1203
Total Docs (3 years)10343
Total Refs7616
Total Cites (3 years)1012
Citable Docs (3 years)7,41
Cites/Doc (2 years)29,38
Ref/DocAims and Scope
Other journals with similar parameters
Nature Reviews Clinical Oncology Q1
CA - A Cancer Journal for Clinicians Q1
JAMA oncology Q1
Cancer Discovery Q1
Journal of the National Cancer Institute Q1
Best articles
(111Indium-DTPA-D-Phe) octreotide scintigraphy in the diagnostic assessment of palpable breast lumps
View more13-Cis-retinoic acid and alphainterferon in advanced squamous cell cancer of the oesophagus
View more163 O - Aortic infuslon (ADM, MMC, CDDP) and stop-flow (MMC, ADM) for systemically pretreated and progresslve FLGO III c and IV ovarian cancer-45 patients
View more26 P - Monitoring of neurotoxicity of taxanes
View more47 P - The role of basic fibroblast growth factor (bFGF) in human non small cell lung cancer (NSCLC)
View more74 O - Selective anti-leukemic potential of HLA-incompatible bone marrow transplants
View moreA Glimpse of the Future. New Directions in the Treatment of Colorectal Cancer
View moreA high pretreatment serum level of VEGF is associated with poor outcome in small cell lung cancer
View moreA new standard treatment for advanced premenopausal breast cancer: A meta-analysis of the Combined Hormonal Agent Trialists Group (CHAT)
View moreA novel herpes vector for the high efficiency transduction of primary hematopoietic cells
View moreA phase II study of high-dose octreotide in patients with unresectable pancreatic carcinoma
View moreA phase III randomised study of carboplatin and amifostine (A) vs carboplatin and G-CSF in patients with inoperable non small cell lung cancer (NSCLC)
View moreA pure antiestrogen, IC1182,780, stimulates the growth of tamoxifen-resistant KPL-1 human breast cancer cells in female nude mice
View moreAccumulation of p53 is associated with response to pre-operative chemotherapy in primary operable breast cancer
View moreActive surveillance' for stage I testis cancer
View moreAcute effects of pamidronate administration on serum levels of interleukin-6 in advanced solid tumour patients with bone metastases and their possible implications in the immunotherapy of cancer with interleukin-2
View moreAll-trans retinoic acid enhances gap junctional intercellular communication among renal epithelial cells in vitro treated with renal carcinogens
View moreApoptosis of Ovarian carcinoma cells (N1) by TNF and it's possible targets
View moreB.I.G. - brother is watching you?
View moreB.I.G. - is beautiful
View moreBile duct stents: Is there an increased rate of complications in patients receiving chemotherapy?
View moreBreast conservation in the 21st century
View moreCancer information: a cost-effective intervention
View moreCancer prevention in the year 2025
View more
If you are a journal editor you can claim the journal profile and add new information for the visitors.
Comments